ArticlePharmacology research & perspectives2022

Hypothesis: Amelioration of obesity-induced cognitive dysfunction via a lorcaserin-betahistine combination treatment.

Ike C Dela Peña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.